Triprolidine
From Wikipedia, the free encyclopedia
Antihistamine medication
This article is about the drug. For the Roman province, see Tripolitania. For the city, see Tripoli.
Pharmaceutical compound
| Clinical data | |
|---|---|
| Trade names | Flonase Nighttime Allergy Relief, Actidil, others |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Oral: 4% |
| Protein binding | 90% |
| Metabolism | Hepatic (CYP2D6) |
| Elimination half-life | 4–6 hours |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.934 Edit this at Wikidata |
| Chemical and physical data | |
| Formula | C19H22N2 |
| Molar mass | 278.399g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 60°C (140°F) |
| Solubility in water | 500mg/mL (20°C) |
| |
| [画像:X mark]N[画像:check]Y(what is this?) (verify) | |
Triprolidine is an over-the-counter first-generation antihistamine with strong anticholinergic properties.[1] It is used to combat the symptoms associated with allergies and is sometimes combined with other medications in preparations designed to provide general relief for flu-like symptoms.[2] As with many antihistamines, the most common side effect is drowsiness.[1]
Triprolidine was patented in 1948 and came into medical use in 1953,[3] and has mostly been replaced in popular cold and flu medications by other drugs such as diphenhydramine, promethazine, chlorpheniramine, loratadine and fexofenadine.
See also
[edit ]References
[edit ]- 1 2 Goldsmith P, Dowd PM (January 1993). "The new H1 antihistamines. Treatment of urticaria and other clinical problems". Dermatologic Clinics. 11 (1): 87–95. doi:10.1016/S0733-8635(18)30285-7. PMID 8094649.
- ↑ Williams BO, Liao SH, Lai AA, Arnold JD, Perkins JG, Blum MR, Findlay JW (1984). "Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products". Clinical Pharmacy. 3 (6): 638–43. PMID 6509877.
- ↑ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 546. ISBN 9783527607495.